Interferon alfacon-1

Pharmaceutical drug
  • L03AB09 (WHO)
Legal statusLegal status
  • US: ℞-only
IdentifiersCAS Number
  • 118390-30-0 checkY
DrugBank
  • DB00069 ☒N
ChemSpider
  • none
UNII
  • 56588OP40D
CompTox Dashboard (EPA)
  • DTXSID4040507 Edit this at Wikidata
Chemical and physical dataFormulaC860H1353N227O255S9Molar mass19241.16 g·mol−1 ☒NcheckY (what is this?)  (verify)

Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1]

References

  1. ^ DrugBank DB00069
  • v
  • t
  • e
Immunostimulants (L03)
Endogenous
Cytokines
Colony-stimulating factors
Interferons
Interleukins
Other protein / peptide
Other
Exogenous
  • v
  • t
  • e
Chemokine
  • See here instead.
CSF
Erythropoietin
G-CSF (CSF3)
GM-CSF (CSF2)
M-CSF (CSF1)
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)
  • See here instead.
Thrombopoietin
Interferon
IFNAR (α/β, I)
IFNGR (γ, II)
IFNLR (λ, III)
  • See IL-28R (IFNLR) here instead.
Interleukin
  • See here instead.
TGFβ
  • See here instead.
TNF
  • See here instead.
Others
JAK
(inhibitors)
JAK1
JAK2
JAK3
TYK2
Others


Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e